ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SEER vs HBIO // FREE CASH FLOW YIELD

Seer Inc. (Class A) (NASDAQ) VS. Harvard Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: SEER 3 — HBIO 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SEER VS. HBIO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SEER HBIO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 51.10% 57.70% -6.60 HBIO /gross-margins <GO>
Return on Invested Capital (ROIC) -29.10% -35.00% +5.90 SEER /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — 13.66% — TIE /fcf-yield <GO>
Operating Margin -60.00% -56.10% -3.90 HBIO /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 17.00% -8.10% +25.10 SEER /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 5/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 36.4 66.9 -30.50 HBIO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $93.0M $40.5M $52.5M SEER /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SEER REV HBIO REV SEER GROSS % HBIO GROSS % SEER FCF HBIO FCF
FY 2025 $16.6M $86.5M 51.1% 57.7% -$46.2M $5.5M
FY 2024 $14.2M $94.1M 49.8% 58.2% -$49.7M -$1.2M
FY 2023 $16.7M $112.3M — — -$59.1M $14.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SEER // BETA —
HBIO // BETA —